Single Agent Lenalidomide Activity in Multiple Myeloma Relapse Evidenced Uniquely by CT/PET.
about
Bone formation following lenalidomide-dexamethasone combination therapy in cases of multiple myeloma refractory to high-dose chemotherapy with bortezomib and autologous peripheral blood stem cell transplantation: report of a case and review of the lSuccessful Treatment of Gastric Relapse in Multiple Myeloma with Bortezomib after Autologous Hematopoietic Stem Cell Transplantation (autoHSCT).
P2860
Single Agent Lenalidomide Activity in Multiple Myeloma Relapse Evidenced Uniquely by CT/PET.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Single Agent Lenalidomide Acti ...... Evidenced Uniquely by CT/PET.
@ast
Single Agent Lenalidomide Acti ...... Evidenced Uniquely by CT/PET.
@en
type
label
Single Agent Lenalidomide Acti ...... Evidenced Uniquely by CT/PET.
@ast
Single Agent Lenalidomide Acti ...... Evidenced Uniquely by CT/PET.
@en
prefLabel
Single Agent Lenalidomide Acti ...... Evidenced Uniquely by CT/PET.
@ast
Single Agent Lenalidomide Acti ...... Evidenced Uniquely by CT/PET.
@en
P2093
P2860
P356
P1476
Single Agent Lenalidomide Acti ...... e Evidenced Uniquely by CT/PET
@en
P2093
Alfonso Cerase
Giulia Papini
Marzia Defina
Monica Bocchia
Vania Rossi
P2860
P304
P356
10.4084/MJHID.2012.041
P577
2012-06-18T00:00:00Z